Eagle Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-176,643
Closed -$11.5M 641
2019
Q4
$11.5M Sell
176,643
-362,861
-67% -$23.6M 0.06% 291
2019
Q3
$33.5M Buy
539,504
+15,892
+3% +$987K 0.17% 188
2019
Q2
$37.3M Sell
523,612
-939
-0.2% -$66.9K 0.19% 190
2019
Q1
$41.1M Sell
524,551
-186,020
-26% -$14.6M 0.22% 176
2018
Q4
$60.2M Buy
710,571
+64,964
+10% +$5.5M 0.38% 94
2018
Q3
$111M Sell
645,607
-31,253
-5% -$5.35M 0.53% 41
2018
Q2
$87.5M Sell
676,860
-22,090
-3% -$2.85M 0.47% 65
2018
Q1
$72M Sell
698,950
-30,005
-4% -$3.09M 0.39% 85
2017
Q4
$62.5M Sell
728,955
-55,415
-7% -$4.75M 0.34% 99
2017
Q3
$66.6M Sell
784,370
-2,448
-0.3% -$208K 0.38% 78
2017
Q2
$59.6M Buy
786,818
+56,568
+8% +$4.28M 0.36% 89
2017
Q1
$48.2M Sell
730,250
-2,092
-0.3% -$138K 0.3% 100
2016
Q4
$46.4M Buy
732,342
+461,990
+171% +$29.3M 0.31% 103
2016
Q3
$17.2M Buy
270,352
+39,611
+17% +$2.52M 0.12% 237
2016
Q2
$17.2M Sell
230,741
-26,824
-10% -$2M 0.12% 237
2016
Q1
$17.2M Buy
257,565
+2,205
+0.9% +$147K 0.12% 244
2015
Q4
$17.3M Buy
255,360
+52,516
+26% +$3.55M 0.12% 239
2015
Q3
$10.8M Buy
202,844
+1,547
+0.8% +$82.7K 0.07% 321
2015
Q2
$12.7M Buy
201,297
+26,774
+15% +$1.69M 0.07% 307
2015
Q1
$8.4M Sell
174,523
-1,985
-1% -$95.5K 0.05% 354
2014
Q4
$5.86M Sell
176,508
-5,251
-3% -$174K 0.03% 396
2014
Q3
$5.33M Sell
181,759
-16,542
-8% -$485K 0.03% 424
2014
Q2
$7.71M Buy
198,301
+4,053
+2% +$157K 0.04% 378
2014
Q1
$8.15M Buy
194,248
+1,797
+0.9% +$75.4K 0.04% 386
2013
Q4
$6.31M Sell
192,451
-88,137
-31% -$2.89M 0.04% 388
2013
Q3
$7.45M Buy
+280,588
New +$7.45M 0.04% 419